Magnetar Financial’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Magnetar Financial’s Portfolio DALS Stock Details DALS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-655,522	Closed	-$6.73M	–	670
2023 Q2	$6.73M	Sell	655,522 -258,217	-28%	-$2.64M	0.15%	108
2023 Q1	$9.25M	Sell	913,739 -22,262	-2%	-$224K	0.18%	111
2022 Q4	$9.34M	Hold	936,001	–	–	0.16%	159
2022 Q3	$9.11M	Sell	936,001 -56,889	-6%	-$553K	0.13%	201
2022 Q2	$9.62K	Buy	992,890 +1,584	+0.2%	+$15.4K	0.1%	191
2022 Q1	$9.66M	Sell	991,306 -5,707	-0.6%	-$55.1K	0.1%	201
2021 Q4	$9.78M	Buy	997,013 +66,966	+7%	+$656K	0.1%	221
2021 Q3	$9.14M	Buy	+930,047	New	+$9.19M	0.09%	228

Magnetar Financial's DALS Position: Q3 2023 in Review

Magnetar Financial sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 655,522 shares — an estimated $6.73M sold.

Magnetar Financial first reported a position in DALS in Q3 2021 and held it in 8 quarters. The position peaked at $9.78M in Q4 2021. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

Magnetar Financial reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Magnetar Financial sold 655,522 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $6.73M.
Magnetar Financial first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q3 2021 and held it in 8 quarters.
Magnetar Financial's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $9.78M in Q4 2021.
0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on Magnetar Financial's 13F filing for Q3 2023, filed 14 Nov 2023.